CD14 and adenoviridae infectious disease: Interestingly, we found that the efficacy of adenovirus infection into CD14+ monocytes was significantly decreased after removing CD3+ T lymphocytes from PBMC samples of Ad-seropositive individuals (preexisting virus-specific CD3+ T cells).